241 related articles for article (PubMed ID: 8439212)
21. A two-step enriched-nested PCR technique enhances sensitivity for detection of codon 12 K-ras mutations in pancreatic adenocarcinoma.
Banerjee SK; Makdisi WF; Weston AP; Campbell DR
Pancreas; 1997 Jul; 15(1):16-24. PubMed ID: 9211488
[TBL] [Abstract][Full Text] [Related]
22. Detection of K-ras gene mutations in plasma DNA of patients with pancreatic adenocarcinoma: correlation with clinicopathological features.
Yamada T; Nakamori S; Ohzato H; Oshima S; Aoki T; Higaki N; Sugimoto K; Akagi K; Fujiwara Y; Nishisho I; Sakon M; Gotoh M; Monden M
Clin Cancer Res; 1998 Jun; 4(6):1527-32. PubMed ID: 9626473
[TBL] [Abstract][Full Text] [Related]
23. Relationships between c-Ki-ras mutations, HPV types, and prognostic indicators in invasive endocervical adenocarcinomas.
Koulos JP; Wright TC; Mitchell MF; Silva E; Atkinson EN; Richart RM
Gynecol Oncol; 1993 Mar; 48(3):364-9. PubMed ID: 8385060
[TBL] [Abstract][Full Text] [Related]
24. [Detection of c-Ki-ras oncogene codon 12 point mutations in lung carcinoma, gastric carcinoma and hepatic carcinoma].
Cui Q; Wang Z; Chen J; Liu T
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1996 Apr; 18(2):95-8. PubMed ID: 9208596
[TBL] [Abstract][Full Text] [Related]
25. Patterns of K-ras codon 12 and 13 mutations found in pancreatic adenocarcinoma of 30 Chinese patients by microdissection, PCR and direct sequencing.
Wei S; Liang Z; Gao J; Wu S; Zhu H; Liu H; Liu T
J Gastroenterol Hepatol; 2005 Jan; 20(1):67-72. PubMed ID: 15610449
[TBL] [Abstract][Full Text] [Related]
26. Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma.
Tada M; Omata M; Kawai S; Saisho H; Ohto M; Saiki RK; Sninsky JJ
Cancer Res; 1993 Jun; 53(11):2472-4. PubMed ID: 8495407
[TBL] [Abstract][Full Text] [Related]
27. Detection of point mutation in K-ras oncogene at codon 12 in pancreatic diseases.
Ren YX; Xu GM; Li ZS; Song YG
World J Gastroenterol; 2004 Mar; 10(6):881-4. PubMed ID: 15040037
[TBL] [Abstract][Full Text] [Related]
28. Ki-ras codon 12 point and P53 mutations: a molecular examination of the main tumor, liver, portal vein, peripheral arterial blood and para-aortic lymph node in pancreatic cancer.
Yamaguchi K; Chijiiwa K; Torato N; Kinoshita M; Tanaka M
Am J Gastroenterol; 2000 Aug; 95(8):1939-45. PubMed ID: 10950039
[TBL] [Abstract][Full Text] [Related]
29. Detection of pancreatic carcinoma: diagnostic value of K-ras mutations in circulating DNA from serum.
Theodor L; Melzer E; Sologov M; Idelman G; Friedman E; Bar-Meir S
Dig Dis Sci; 1999 Oct; 44(10):2014-9. PubMed ID: 10548352
[TBL] [Abstract][Full Text] [Related]
30. Analysis of K-ras gene mutations in rare pancreatic and ampullary tumours.
Ebert MP; Hoffmann J; Schneider-Stock R; Kasper HU; Schulz HU; Lippert H; Roessner A; Malfertheiner P
Eur J Gastroenterol Hepatol; 1998 Dec; 10(12):1025-9. PubMed ID: 9895049
[TBL] [Abstract][Full Text] [Related]
31. Ki-ras point mutation in different types of colorectal carcinomas in early stages.
Kojima M; Konishi F; Tsukamoto T; Yamashita K; Kanazawa K
Dis Colon Rectum; 1997 Feb; 40(2):161-7. PubMed ID: 9075750
[TBL] [Abstract][Full Text] [Related]
32. Analysis of Ki-ras codon 12 mutations in the duodenal juice of patients with pancreatic cancer.
Iguchi H; Sugano K; Fukayama N; Ohkura H; Sadamoto K; Ohkoshi K; Seo Y; Tomoda H; Funakoshi A; Wakasugi H
Gastroenterology; 1996 Jan; 110(1):221-6. PubMed ID: 8536860
[TBL] [Abstract][Full Text] [Related]
33. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization.
Hruban RH; van Mansfeld AD; Offerhaus GJ; van Weering DH; Allison DC; Goodman SN; Kensler TW; Bose KK; Cameron JL; Bos JL
Am J Pathol; 1993 Aug; 143(2):545-54. PubMed ID: 8342602
[TBL] [Abstract][Full Text] [Related]
34. Detection of K-ras point mutations at codon 12 in pancreatic juice for the diagnosis of pancreatic cancer by hybridization protection assay: a simple method for the determination of the types of point mutation.
Watanabe H; Miyagi C; Yamaguchi Y; Satomura Y; Ohta H; Motoo Y; Okai T; Yoshimura T; Tsuji Y; Sawabu N
Jpn J Cancer Res; 1996 May; 87(5):466-74. PubMed ID: 8641983
[TBL] [Abstract][Full Text] [Related]
35. [Detection of point mutations of C-Ki-ras oncogene in colon cancer by PCR using specific oligonucleotide probes].
Xu KM
Zhonghua Zhong Liu Za Zhi; 1992 Jul; 14(4):261-3. PubMed ID: 1396073
[TBL] [Abstract][Full Text] [Related]
36. [Detection of ras gene mutations of pancreatic tumors by polymerase chain reaction and direct sequencing method].
Tada M; Yokosuka O; Omata M; Ohto M; Isono K
Nihon Shokakibyo Gakkai Zasshi; 1989 Nov; 86(11):2566-71. PubMed ID: 2689731
[TBL] [Abstract][Full Text] [Related]
37. Mutations of the Ki-ras oncogene in carcinoma of the endometrium.
Caduff RF; Johnston CM; Frank TS
Am J Pathol; 1995 Jan; 146(1):182-8. PubMed ID: 7856726
[TBL] [Abstract][Full Text] [Related]
38. Differential activation of the c-Ki-ras-2 proto-oncogene in human colorectal carcinoma.
Halatsch ME; Hirsch-Ernst KI; Weinel RJ; Kahl GF
Anticancer Res; 1998; 18(4A):2323-5. PubMed ID: 9703874
[TBL] [Abstract][Full Text] [Related]
39. Stability of ras oncogene mutation in the human tumor xenografts through serial passages.
Kijima H; Abe Y; Yamazaki H; Ohnishi Y; Ueyama Y; Tamaoki N; Nakamura M
Anticancer Res; 1994; 14(6B):2583-7. PubMed ID: 7872685
[TBL] [Abstract][Full Text] [Related]
40. Clinical application of ras gene mutation for diagnosis of pancreatic adenocarcinoma.
Tada M; Omata M; Ohto M
Gastroenterology; 1991 Jan; 100(1):233-8. PubMed ID: 1983826
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
